Literature DB >> 16697063

Trk receptor binding and neurotrophin/fibroblast growth factor (FGF)-dependent activation of the FGF receptor substrate (FRS)-3.

Scott J Dixon1, James I S MacDonald, Kim N Robinson, Christopher J Kubu, Susan O Meakin.   

Abstract

We have investigated the signaling properties of the fibroblast growth factor (FGF) receptor substrate 3 (FRS3), also known as SNT-2 or FRS2beta, in neurotrophin-dependent differentiation in comparison with the related adapter FRS2 (SNT1 or FRS2alpha). We demonstrate that FRS3 binds all neurotrophin Trk receptor tyrosine kinases and becomes tyrosine phosphorylated in response to NGF, BDNF, NT-3 and FGF stimulation in transfected cells and/or primary cortical neurons. Second, the signaling molecules Grb2 and Shp2 bind FRS3 at consensus sites that are highly conserved among FRS family members and that Shp2, in turn, becomes tyrosine phosphorylated. While FRS3 over-expression in PC12 cells neither increases NGF-induced neuritogenesis nor activation of Map kinase/AKT, comparable to previous reports on FRS2, over-expression of a chimeric adapter containing the PH/PTB domains of the insulin receptor substrate (IRS) 2, in place of the PTB domain of FRS3 (IRS2-FRS3) supports insulin-dependent Map kinase activation and neurite outgrowth in PC12 cells. Collectively, these data demonstrate that FRS3 supports ligand-induced Map kinase activation and that the chimeric IRS2-FRS3 adapter is stimulating sufficient levels of activated MapK to support neurite outgrowth in PC12 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697063     DOI: 10.1016/j.bbamcr.2006.02.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  The signaling adapter, FRS2, facilitates neuronal branching in primary cortical neurons via both Grb2- and Shp2-dependent mechanisms.

Authors:  Li Zhou; Asghar Talebian; Susan O Meakin
Journal:  J Mol Neurosci       Date:  2014-08-27       Impact factor: 3.444

2.  Neurotrophin and FGF Signaling Adapter Proteins, FRS2 and FRS3, Regulate Dentate Granule Cell Maturation and Excitatory Synaptogenesis.

Authors:  Sayan Nandi; Karina Alviña; Pablo J Lituma; Pablo E Castillo; Jean M Hébert
Journal:  Neuroscience       Date:  2017-11-16       Impact factor: 3.590

3.  Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor.

Authors:  Yongyou Zhang; Kerstin McKeehan; Yongshun Lin; Jue Zhang; Fen Wang
Journal:  Mol Endocrinol       Date:  2007-09-27

4.  TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.

Authors:  Ramesh Singh; Dileep Karri; Hong Shen; Jiangyong Shao; Subhamoy Dasgupta; Shixia Huang; Dean P Edwards; Michael M Ittmann; Bert W O'Malley; Ping Yi
Journal:  J Clin Invest       Date:  2018-06-18       Impact factor: 14.808

5.  Molecular networks in FGF signaling: flotillin-1 and cbl-associated protein compete for the binding to fibroblast growth factor receptor substrate 2.

Authors:  Ana Tomasovic; Stephanie Traub; Ritva Tikkanen
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

6.  Role and expression of FRS2 and FRS3 in prostate cancer.

Authors:  Tania Valencia; Ajay Joseph; Naveen Kachroo; Steve Darby; Susan Meakin; Vincent J Gnanapragasam
Journal:  BMC Cancer       Date:  2011-11-11       Impact factor: 4.430

7.  NGF causes TrkA to specifically attract microtubules to lipid rafts.

Authors:  Shona Pryor; Gretchen McCaffrey; Lindsay R Young; Mark L Grimes
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

8.  The pseudophosphatase MK-STYX induces neurite-like outgrowths in PC12 cells.

Authors:  Brittany M Flowers; Lauren E Rusnak; Kristen E Wong; Dallas A Banks; Michelle R Munyikwa; Alexander G McFarland; Shantá D Hinton
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

9.  TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype.

Authors:  Antonietta R Farina; Natalia Di Ianni; Lucia Cappabianca; Pierdomenico Ruggeri; Marzia Ragone; Giulia Ianni; Alberto Gulino; Andrew R Mackay
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

10.  Flotillins in receptor tyrosine kinase signaling and cancer.

Authors:  Antje Banning; Nina Kurrle; Melanie Meister; Ritva Tikkanen
Journal:  Cells       Date:  2014-02-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.